AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

Novartis’ Don Ganem tapped as a scientific advisor for the Chan Zuckerberg Biohub

Novartis supports promising young scientists who want to improve their chances to attain advanced science degrees.

Novartis researcher Joana Silva had a life-changing experience with a mentor.

The molecule restores the activity of neurons and neural circuits in a model of the disease.

With Nerve Live, Novartis is harnessing the power of data for the benefit of patients.

The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.

Using new technologies, researchers have developed a deeper understanding of how cells function, changing conceptions of disease.